AR060205A1 - SYNERGISTIC PHARMACEUTICAL COMPOSITION OF CARISOPRODOL AND LISINE CLONIXINATE - Google Patents

SYNERGISTIC PHARMACEUTICAL COMPOSITION OF CARISOPRODOL AND LISINE CLONIXINATE

Info

Publication number
AR060205A1
AR060205A1 ARP070104561A ARP070104561A AR060205A1 AR 060205 A1 AR060205 A1 AR 060205A1 AR P070104561 A ARP070104561 A AR P070104561A AR P070104561 A ARP070104561 A AR P070104561A AR 060205 A1 AR060205 A1 AR 060205A1
Authority
AR
Argentina
Prior art keywords
carisoprodol
clonixinate
lisine
pharmaceutical composition
synergistic pharmaceutical
Prior art date
Application number
ARP070104561A
Other languages
Spanish (es)
Inventor
Sanchez Carmen Miguel Gomez
Suarez Graciela De Lo Aguilera
Lora Martha Rosaura Juarez
Original Assignee
Farmaceuticos Rayere S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceuticos Rayere S A filed Critical Farmaceuticos Rayere S A
Publication of AR060205A1 publication Critical patent/AR060205A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones farmacéuticas que contienen un relajante muscular conocido como carisoprodol y el otro un analgésico anti-inflamatorio no esteroideo conocido como clonixinato de lisina. Cuando se combinan ambos fármacos en proporciones específicas la combinacion produce efectos farmacologicos que indican una sinergia, por lo que es posible usar menos cantidad de ambos fármacos para lograr el mismo grado de analgesia y relajamiento muscular que cuando se usan solos, con la ventaja de tener menos efectos adversos.Pharmaceutical compositions containing a muscle relaxant known as carisoprodol and the other a non-steroidal anti-inflammatory analgesic known as lysine clonixinate. When both drugs are combined in specific proportions the combination produces pharmacological effects that indicate synergy, so it is possible to use less of both drugs to achieve the same degree of analgesia and muscle relaxation as when used alone, with the advantage of having Less adverse effects

ARP070104561A 2006-10-30 2007-10-12 SYNERGISTIC PHARMACEUTICAL COMPOSITION OF CARISOPRODOL AND LISINE CLONIXINATE AR060205A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2006/000118 WO2008054188A1 (en) 2006-10-30 2006-10-30 Synergistic pharmaceutical composition comprising lysine clonixinate and carisoprodol

Publications (1)

Publication Number Publication Date
AR060205A1 true AR060205A1 (en) 2008-06-04

Family

ID=39344480

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104561A AR060205A1 (en) 2006-10-30 2007-10-12 SYNERGISTIC PHARMACEUTICAL COMPOSITION OF CARISOPRODOL AND LISINE CLONIXINATE

Country Status (4)

Country Link
AR (1) AR060205A1 (en)
CL (1) CL2007003136A1 (en)
MX (1) MX2007012517A (en)
WO (1) WO2008054188A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1103205A2 (en) * 2011-06-03 2014-02-25 Eurofarma Lab Ltda ORAL PHARMACEUTICAL COMPOSITION AND USE OF ORAL PHARMACEUTICAL COMPOSITION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205492A1 (en) * 1984-12-26 1986-12-30 SUNSHINE, Abraham Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic

Also Published As

Publication number Publication date
CL2007003136A1 (en) 2008-02-15
WO2008054188A1 (en) 2008-05-08
MX2007012517A (en) 2009-02-26

Similar Documents

Publication Publication Date Title
MX2009004203A (en) Acetaminophen / ibuprofen combinations.
CL2008001268A1 (en) Compounds derived from n- [6-amino-5-aryl-pyridin-2-yl] -carboxamide; pharmaceutical composition that includes them; combined pharmaceutical composition comprising them together with another additional pharmacological agent; and use them in the treatment of pain.
UA87841C2 (en) Topical composition containing ambroxol
FI3782612T3 (en) Oral formulations of cytidine analogs and methods of use thereof
CL2008003901A1 (en) Use of a hedgehog inhibitor to extend relapse-free survival in a patient with cancer, who is on chemotherapy or has previously been treated with chemotherapy.
EA201100958A1 (en) PHARMACEUTICAL ORAL DOSED DOSAGE FORM BASED ON DPP IV INHIBITORS
PE20081114A1 (en) DUAL AGENT BIOADHESIVE PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE
CL2008000610A1 (en) COMPOSITION IN THE FORM OF TRANSDERMIC OR TRANSMUCOSE DOSAGE THAT INCLUDES A RELATIONSHIP IN BUPRENORFINE WEIGHT TO NALOXONE BETWEEN 2.1: 1 AND 8: 1, USEFUL FOR THE TREATMENT OF PAIN.
BRPI0508680A (en) natural cooling composition, flavoring composition, ready-to-eat product, and use of a composition
BRPI0816798A2 (en) compound, pharmaceutical composition, methods for inhibiting the action of glycogen synthase kinase-3, and for treating, preventing or ameliorating a disease, use of a compound, and article of manufacture
UY28517A1 (en) NEW COMBINATION
BRPI0513938B8 (en) pharmaceutical composition containing drospirenone and ethinylestradiol
EA200901237A1 (en) APPLICATION OF DIMIRACETAM IN THE TREATMENT OF CHRONIC PAIN
AR052830A1 (en) CLADRIBINE REGIME TO TREAT MULTIPLE SCLEROSIS
AR030957A1 (en) ANALGESIC AND GLUCOSAMINE COMPOSITIONS
PE20090625A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BUPRENORPHINE AND NALMEFENE
BRPI0810773A2 (en) PHARMACEUTICAL COMPOSITION, METHODS TO TREAT PAIN IN A MAMMER, TO DEPRESS DEPRESSION IN A MAMMER, TO TREAT A DISORDER IN A PATIENT, TO MANUFACTURE A COMPOUND, AND TO INHIBIT NOREPINEPHRINE COMPOSITION, AND USE.
CL2008001477A1 (en) Pharmaceutical composition composed of the synergistic combination of an anticonvulsant agent such as gabapentin and a non-steroidal anti-inflammatory agent such as meloxicam, the concentration ranges present for gabapentin are 3 to 300 mg and 0.1 to 30 mg for meloxicam; and use to treat neuropathic pain
AR060205A1 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITION OF CARISOPRODOL AND LISINE CLONIXINATE
MXPA02010828A (en) Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain.
CO6331430A2 (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A KETOROLACO SALT AND VITAMINS OF COMPLEX B FOR THE TREATMENT OF NEURALGIA
AR044831A1 (en) FLUPIRTINA INJECTABLE ADMINISTRATION FORM
ECSP066836A (en) PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS
AR055807A1 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITION OF DICHLOFENACO AND LISINE CLONIXINATE
BRPI0604461A (en) stable pharmaceutical composition of carisoprodol and meloxicam

Legal Events

Date Code Title Description
FB Suspension of granting procedure